Login
$XCUR
$1.07 -$0.02 (1.83%) Close

Company Executives

$XCUR Management Team

Dr. Josephine Cardarelli

Chief Scientific Officer

Age -
Compensation -
Sex Female

Mr. Jung Soo Kim

President

Chief Executive Officer

Director

Age 53
Compensation -
Sex Male

Mr. Gyuyeob Lee

Chief Financial Officer

Company Secretary

Age 40
Compensation -
Sex Male
Directors
5
serving now
Independent
3 of 3
stated in the proxy; 2 not stated
Average tenure
0.8 years
from year joined
CEO also chairs the board
Not stated
no chair stated
Director Age On board Independent Committees Other public boards 2024 pay Source
Aejin Hwang
43 2025
0 years
Independent
Audit Committee
None stated Not stated
Sangjin Yeo
54 2025
0 years
Independent
Audit Committee · Chair
None stated Not stated
Andy Yoo
46 2024
1 year
Not stated None stated HiTron Paid as CEO
Dongho Lee
63 2023
2 years
Independent
Compensation Committee
None stated $20,000
Seung Ik Baik
39 2024
1 year
Not stated None stated The Technology Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

7 disclosed in the proxy filed Sep 23, 2025
HiTron Systems Inc.
Mr. Yoo and Mr. Baik were designated by HiTron
Amount not stated
2024

Common stock purchase agreement under which the Company agreed to sell 433,333 shares of common stock to HiTron at $3.00 per share.

HiTron Systems Inc.
Mr. Yoo and Mr. Baik were designated by HiTron
$8.7 million
2024

Subsequent common stock purchase agreement under which the Company agreed to sell 2,900,000 additional shares of common stock to HiTron at $3.00 per share.

SangSang Investment & Securities Co., Ltd.
beneficially owns 7% of the outstanding shares of Common Stock
Amount not stated
2024

Common stock purchase agreement under which the Company agreed to sell 433,332 shares of common stock to SangSang at $4.61 per share.

CBI USA, Inc.
Gross proceeds of $5,440,000

Securities purchase agreement and private placement of 680,000 shares of common stock to CBI USA at $8.00 per share.

DGP Co., Ltd.
affiliate of CBI USA, Inc.
Amount not stated

DGP made a loan to CBI USA that funded CBI USA's acquisition of the 680,000 shares; DGP later exercised the option and acquired those shares.

With CBI USA Open in proxy
Paul Kang
director of the Company from February 2023 through March 2025 and former Chief Executive Officer
Amount not stated
2023 and 2024

Business development consulting services provided through entities controlled by Mr. Kang in 2023.

Alta
Mr. Kang, a director of the Company from February 2023 through March 2025 and the former Chief Executive Officer of the Company, is the President
Amount not stated

Consulting agreement with Alta, of which Mr. Kang is President, with an initial fee and a monthly fee.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support